We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » SIZE NOT SOLE CRITERIA FOR CANCER TRIALS IND EXEMPTION
SIZE NOT SOLE CRITERIA FOR CANCER TRIALS IND EXEMPTION
January 23, 2004
Decisions on whether a clinical cancer study should be exempt from investigational new drug (IND) regulations will no longer be based solely on the size of the study, the FDA stated in a revised guidance issued earlier this month.